CoChat
Sign Up
Cited by 68

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity

Regev, Keren, Healy, Brian C., Khalid, Fariha, Paul, Anu, Chu, Renxin, Tauhid, Shahamat, Tummala, Subhash, Diaz-Cruz, Camilo, Raheja, Radhika, Mazzola, Maria A., von Glehn, Felipe, Kivisakk, Pia, Dupuy, Sheena L., Kim, Gloria, Chitnis, Tanuja, Weiner, Howard L., Gandhi, Roopali, Bakshi, Rohit·2017·JAMA Neurology
DOI 10.1001/jamaneurol.2016.5197PMC PMC6014611
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2016.5197

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 86

  1. [1]Kutzelnigg A Lassmann H Pathology of multiple sclerosis and related inflammatory demyelinating diseases Handb Clin Neurol 2014 122 15 58 24507512
  2. [2]Geurts JJ Calabrese M Fisher E Rudick RA Measurement and clinical effect of grey matter pathology in multiple sclerosis Lancet Neurol 2012 11 12 1082 1092 23153407
  3. [3]Filippi M Rocca MA Arnold DL EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis Eur J Neurol 2006 13 4 313 325 16643308
  4. [4]Filippi M Wolinsky JS Comi G CORAL Study Group Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study Lancet Neurol 2006 5 3 213 220 16488376
  5. [6]Bakshi R Dandamudi VS Neema M De C Bermel RA Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis J Neuroimaging 2005 15 4 suppl 30S 45S 16385017
  6. [7]Filippi M MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment J Neurol 2015 262 1 1 6 24723117
  7. [8]Pirko I Lucchinetti CF Sriram S Bakshi R Gray matter involvement in multiple sclerosis Neurology 2007 68 9 634 642 17325269
  8. [9]Zivadinov R Bakshi R Role of MRI in multiple sclerosis; I: inflammation and lesions Front Biosci 2004 9 665 683 14766399
  9. [10]van Walderveen MA Kamphorst W Scheltens P Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis Neurology 1998 50 5 1282 1288 9595975
  10. [11]Kim G Tauhid S Dupuy SL An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis J Neurol 2016 263 3 531 538 26754005 PMC4785194
  11. [12]Truyen L van Waesberghe JH van Walderveen MA Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis Neurology 1996 47 6 1469 1476 8960729
  12. [13]Janardhan V Bakshi R Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis Arch Neurol 2000 57 10 1485 1491 11030802
  13. [14]Tauhid S Chu R Sasane R Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis J Neurol 2015 262 11 2425 2432 26205635 PMC4639581
  14. [15]Tauhid S Neema M Healy BC Weiner HL Bakshi R MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis J Neurol Sci 2014 346 1–2 250 254 25220114
  15. [16]Sormani MP Arnold DL De Stefano N Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis Ann Neurol 2014 75 1 43 49 24006277
  16. [17]Sanfilipo MP Benedict RH Sharma J Weinstock-Guttman B Bakshi R The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction Neuroimage 2005 26 4 1068 1077 15961046
  17. [18]Sanfilipo MP Benedict RH Weinstock-Guttman B Bakshi R Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis Neurology 2006 66 5 685 692 16534104
  18. [19]Oh J Seigo M Saidha S Spinal cord normalization in multiple sclerosis J Neuroimaging 2014 24 6 577 584 24593281 PMC4156567
  19. [20]Bot JC Barkhof F Polman CH Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination Neurology 2004 62 2 226 233 14745058
  20. [21]Cohen AB Neema M Arora A The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis J Neuroimaging 2012 22 2 122 128 21447024 PMC3128174
  21. [22]Ørom UA Nielsen FC Lund AH MicroRNA-10a binds the 5′UTRofribosomal protein mRNAs and enhances their translation Mol Cell 2008 30 4 460 471 18498749
  22. [23]Lytle JR Yario TA Steitz JA Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR Proc Natl Acad Sci U S A 2007 104 23 9667 9672 17535905 PMC1887587
  23. [24]Zhou X Duan X Qian J Li F Abundant conserved microRNA target sites in the 5′-untranslated region and coding sequence Genetica 2009 137 2 159 164 19578934
  24. [25]Ebert MS Sharp PA Roles for microRNAs in conferring robustness to biological processes Cell 2012 149 3 515 524 22541426 PMC3351105
  25. [26]Mendell JT Olson EN MicroRNAs in stress signaling and human disease Cell 2012 148 6 1172 1187 22424228 PMC3308137
  26. [27]Mitchell PS Parkin RK Kroh EM Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 2008 105 30 10513 10518 18663219 PMC2492472
  27. [28]Haghikia A Haghikia A Hellwig K Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study Neurology 2012 79 22 2166 2170 23077021
  28. [29]Mestdagh P Hartmann N Baeriswyl L Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study Nat Methods 2014 11 8 809 815 24973947
  29. [30]Guerau-de-Arellano M Smith KM Godlewski J Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity Brain 2011 134 pt 12 3578 3589 22088562 PMC3235556
  30. [31]Eisele S Krumbholz M Fischer MT Prospects of transcript profiling for mRNAs and microRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions Brain Pathol 2012 22 5 607 618 22233114 PMC8057623
  31. [32]Thamilarasan M Koczan D Hecker M Paap B Zettl UK MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis Autoimmun Rev 2012 11 3 174 179 21621006
  32. [33]Gandhi R miRNA in multiple sclerosis: search for novel biomarkers Mult Scler 2015 21 9 1095 1103 25921051
  33. [34]Gandhi R Healy B Gholipour T Circulating microRNAs as biomarkers for disease staging in multiple sclerosis Ann Neurol 2013 73 6 729 740 23494648
  34. [35]Huang Q Xiao B Ma X MicroRNAs associated with the pathogenesis of multiple sclerosis J Neuroimmunol 2016 295–296 148 161 27235360
  35. [36]Eikelenboom MJ Petzold A Lazeron RH Multiple sclerosis: neurofilament light chain antibodies are correlated to cerebral atrophy Neurology 2003 60 2 219 223 12552034
  36. [37]Gauthier SA Glanz BI Mandel M Weiner HL A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study Autoimmun Rev 2006 5 8 532 536 17027888
  37. [39]Kurtzke JF On the origin of EDSS Mult Scler Relat Disord 2015 4 2 95 103 25787185
  38. [40]Oommen VV Tauhid S Healy BC The effect of fingolimod on conversion of acute gadolinium-enhancing lesions to chronic T1 hypointensities in multiple sclerosis J Neuroimaging 2016 26 2 184 187 26445919 PMC5057343
  39. [41]Bakshi R Neema M Healy BC Predicting clinical progression in multiple sclerosis with the Magnetic Resonance Disease Severity Scale Arch Neurol 2008 65 11 1449 1453 19001162 PMC2762216
  40. [42]Moodie J Healy BC Buckle GJ Magnetic Resonance Disease Severity Scale (MRDSS) for patients with multiple sclerosis: a longitudinal study J Neurol Sci 2012 315 1–2 49 54 22209496 PMC3319060
  41. [43]Chu R Tauhid S Glanz BI Whole brain volume measured from 1.5T versus 3T MRI in healthy subjects and patients with multiple sclerosis J Neuroimaging 2016 26 1 62 67 26118637 PMC4755143
  42. [44]Sharma J Sanfilipo MP Benedict RH Weinstock-Guttman B Munschauer FE III Bakshi R Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation A JNR Am J Neuroradiol 2004 25 6 985 996 PMC7975687 15205136
  43. [45]Horsfield MA Sala S Neema M Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis Neuroimage 2010 50 2 446 455 20060481 PMC2830007
  44. [46]Healy BC Arora A Hayden DL Approaches to normalization of spinal cord volume: application to multiple sclerosis J Neuroimaging 2012 22 3 e12 e19 21854479 PMC3290735
  45. [47]Kim G Khalid F Oommen VV T1-vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis BMC Neurol 2015 15 124 26227960 PMC4521382
  46. [48]Bermel RA Sharma J Tjoa CW Puli SR Bakshi R Asemiautomated measure of whole-brain atrophy in multiple sclerosis J Neurol Sci 2003 208 1–2 57 65 12639726
  47. [49]Ma X Zhou J Zhong Y Expression, regulation and function of microRNAs in multiple sclerosis Int J Med Sci 2014 11 8 810 818 24936144 PMC4057480
  48. [50]Dong H Li J Huang L Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer’s disease Dis Markers 2015 2015 625659 26078483 PMC4452867
  49. [51]Sun M Yamashita T Shang J Time-dependent profiles of micro RNA expression induced by ischemic preconditioning in the gerbil hippocampus Cell Transplant 2015 24 3 367 376 25646661
  50. [53]Regev K Paul A Healy B Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis Neurol Neuroimmunol Neuroinflamm 2016 3 5 e267 27606352 PMC4996540
  51. [54]Muñoz-Culla M Irizar H Castillo-Triviño T Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients Mult Scler 2014 20 14 1851 1859 24852919
  52. [55]Sievers C Meira M Hoffmann F Fontoura P Kappos L Lindberg RL Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects Clin Immunol 2012 144 1 70 79 22659298
  53. [56]Bielekova B Kadom N Fisher E MRI as a marker for disease heterogeneity in multiple sclerosis Neurology 2005 65 7 1071 1076 16217061
  54. [57]Boese AS Saba R Campbell K MicroRNA abundance is altered in synaptoneurosomes during prion disease Mol Cell Neurosci 2016 71 13 24 26658803
  55. [58]Pati S Supeno NE Muthuraju S MicroRNA profiling reveals unique miRNA signatures in IGF-1 treated embryonic striatal stem cell fate decisions in striatal neurogenesis in vitro Biomed Res Int 2014 2014 503162 25254208 PMC4165568
  56. [59]Supeno NE Pati S Hadi RA IGF-1 acts as controlling switch for long-term proliferation and maintenance of EGF/FGF-responsive striatal neural stem cells Int J Med Sci 2013 10 5 522 531 23532711 PMC3607237
  57. [60]Dai C Celestino JC Okada Y Louis DN Fuller GN Holland EC PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo Genes Dev 2001 15 15 1913 1925 11485986 PMC312748
  58. [61]Song J Cho KJ Cheon SY Apoptosis signal-regulating kinase 1 (ASK1) is linked to neural stem cell differentiation after ischemic brain injury Exp Mol Med 2013 45 e69 24357833 PMC3880461
  59. [62]Sørensen SS Nygaard AB Christensen T miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia—an exploratory study Transl Neurodegener 2016 5 6 26981236 PMC4791887
  60. [63]Jiang S Deng C Lv J Nrf2 weaves an elaborate network of neuroprotection against stroke [published online February 5, 2016] Mol Neurobiol 26846360
  61. [64]Liu S-Q Jiang S Li C Zhang B Li Q-J miR-17-92 cluster targets phosphatase and tensin homology and ikaros family zinc finger 4 to promote TH17-mediated inflammation J Biol Chem 2014 289 18 12446 12456 24644282 PMC4007439
  62. [65]Wang LS Li L Li L MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors Blood 2015 125 8 1302 1313 25515961 PMC4335083
  63. [66]Alexander MS Casar JC Motohashi N MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms J Clin Invest 2014 124 6 2651 2667 24789910 PMC4038577
  64. [67]Newton RH Turka LA Regulation of T cell homeostasis and responses by pten Front Immunol 2012 3 151 22715338 PMC3375464
  65. [69]Zhang H Cao H Xu D Zhu K MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway Onco Targets Ther 2016 9 3579 3588 27366095 PMC4913974
  66. [70]Ke T-W Wei P-L Yeh K-T Chen WT-L Cheng Y-W MiR-92a promotes cell metastasis of colorectal cancer through PTEN-mediated PI3K/AKT pathway Ann Surg Oncol 2015 22 8 2649 2655 25515201
  67. [71]Mavrakis KJ Van Der Meulen J Wolfe AL A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL) Nat Genet 2011 43 7 673 678 21642990 PMC4121855
  68. [72]Xu S Ou X Huo J Mir-17-92 regulates bone marrow homing of plasma cells and production of immunoglobulin G2c Nat Commun 2015 6 6764 25881561
  69. [73]John LB Ward AC The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity Mol Immunol 2011 48 9–10 1272 1278 21477865
  70. [74]Neilson JR Zheng GX Burge CB Sharp PA Dynamic regulation of miRNA expression inordered stages of cellular development Genes Dev 2007 21 5 578 589 17344418 PMC1820899
  71. [75]Podshivalova K Salomon DR MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development Crit Rev Immunol 2013 33 5 435 476 24099302 PMC4185288
  72. [76]Saki N Abroun S Soleimani M Involvement of microRNA in T-cell differentiation and malignancy Int J Hematol Oncol Stem Cell Res 2015 9 1 33 49 25802699 PMC4369232
  73. [77]González-Amaro R Cortés JR Sánchez-Madrid F Martín P Is CD69 an effective brake to control inflammatory diseases? Trends Mol Med 2013 19 10 625 632 23954168 PMC4171681
  74. [78]Podojil JR Miller SD Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy Immunol Rev 2009 229 1 337 355 19426232 PMC2845642
  75. [79]Hsu HC Yang P Wu Q Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice Arthritis Rheum 2011 63 7 2038 2048 21305519 PMC3379710
  76. [80]Li Y Kuscu C Banach A miR-181a-5p Inhibits cancer cell migration and angiogenesis via downregulation of matrix metalloproteinase-14 Cancer Res 2015 75 13 2674 2685 25977338 PMC4489986
  77. [81]Klose A Zigrino P Mauch C Monocyte/macrophage MMP-14 modulates cell infiltration and T-cell attraction in contact dermatitis but not in murine wound healing Am J Pathol 2013 182 3 755 764 23438475
  78. [82]Sombekke MH Lukas C Crusius JB HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis Arch Neurol 2009 66 12 1531 1536 20008659
  79. [83]Stromnes IM Cerretti LM Liggitt D Harris RA Goverman JM Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells Nat Med 2008 14 3 337 342 18278054 PMC2813727
  80. [84]Bakshi R Neema M Tauhid S An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2 Neuroreport 2014 25 14 1156 1161 25100554 PMC4166046
  81. [85]Olsen JA Akirav EM Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches J Neurosci Res 2015 93 5 687 696 25287108
  82. [86]Zurawski J Lassmann H Bakshi R Use of magnetic resonance imaging to visualize leptomeningeal inflammation in patients with multiple sclerosis: a review [published online November 28, 2016] JAMA Neurol 10.1001/jamaneurol.2016.4237 27893883 · DOI
  83. [87]Giannetti P Politis M Su P Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [11C](R)-PK11195-PET pilot study Neurobiol Dis 2014 65 203 210 24508617
  84. [88]Haider L Simeonidou C Steinberger G Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron J Neurol Neurosurg Psychiatry 2014 85 12 1386 1395 24899728 PMC4251183
  85. [89]Beer A Biberacher V Schmidt P Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity J Neurol 2016 263 8 1495 1502 27178000
  86. [90]Chen X Liang H Zhang J Zen K Zhang CY Secreted microRNAs: a new form of intercellular communication Trends Cell Biol 2012 22 3 125 132 22260888

Cited by

Sorted by citations

See all 68

Metadata

Authors
Regev, K., Healy, B. C., Khalid, F., Paul, A., Chu, R., Tauhid, S., Tummala, S., Diaz-Cruz, C., Raheja, R., Mazzola, M. A., von Glehn, F., Kivisakk, P., Dupuy, S. L., Kim, G., Chitnis, T., Weiner, H. L., Gandhi, R., & Bakshi, R.
Affiliations
  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts2Biostatistics Center, Massachusetts General Hospital, Boston
  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts3Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
  • Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts3Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts4Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
Venue
JAMA Neurology
Publisher
American Medical Association (AMA)
Published
2017-03-01
Volume
74
Issue
3
Pages
275
ISSN
2168-6149
DOI
10.1001/jamaneurol.2016.5197
PMC
PMC6014611
Cited by
68
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity. https://app.cochat.ai/papers/10.1001/jamaneurol.2016.5197
The paper
Regev, K., Healy, B. C., Khalid, F., Paul, A., Chu, R., Tauhid, S., Tummala, S., Diaz-Cruz, C., Raheja, R., Mazzola, M. A., von Glehn, F., Kivisakk, P., Dupuy, S. L., Kim, G., Chitnis, T., Weiner, H. L., Gandhi, R., & Bakshi, R. (2017). Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2016.5197